 | • レポートコード：GIR-22F19128 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Animal Autogenous Vaccines Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の動物自家ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 動物自家ワクチン市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・家禽、豚、牛、魚、その他 アプリケーション別セグメントは次のように区分されます。 ・大規模農場、家庭用農場 世界の動物自家ワクチン市場の主要な市場プレーヤーは以下のとおりです。 ・Boehringer Ingelheim International、ZOETIS、Gallant Custom Laboratories、Ceva Biovac、Dyntec sro、UVAXX Pte Ltd、Deltamune Animal Health、Genova Labs、Hygieia Biological Laboratories、Vaxxinova、Elanco Animal Health、Addison Biological Laboratory、Phibro Animal Health Corporation、Lohmann Tierzucht、RIPAC-LABOR GmbH、Aquatic Biologicals、Merck、BS-IMMUN GmbH、Ridgeway Biologicals 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、動物自家ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な動物自家ワクチンメーカーの企業概要、2019年～2022年までの動物自家ワクチンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な動物自家ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別動物自家ワクチンの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの動物自家ワクチンのタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での動物自家ワクチン市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および動物自家ワクチンの産業チェーンを掲載しています。 ・第13、14、15章では、動物自家ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 動物自家ワクチンの概要 - タイプ別分析（2017年vs2021年vs2028年）：家禽、豚、牛、魚、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：大規模農場、家庭用農場 - 世界の動物自家ワクチン市場規模・予測 - 世界の動物自家ワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Boehringer Ingelheim International、ZOETIS、Gallant Custom Laboratories、Ceva Biovac、Dyntec sro、UVAXX Pte Ltd、Deltamune Animal Health、Genova Labs、Hygieia Biological Laboratories、Vaxxinova、Elanco Animal Health、Addison Biological Laboratory、Phibro Animal Health Corporation、Lohmann Tierzucht、RIPAC-LABOR GmbH、Aquatic Biologicals、Merck、BS-IMMUN GmbH、Ridgeway Biologicals ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：家禽、豚、牛、魚、その他 ・アプリケーション別分析2017年-2028年：大規模農場、家庭用農場 ・動物自家ワクチンの北米市場分析 - 動物自家ワクチンの北米市場：タイプ別市場規模2017年-2028年 - 動物自家ワクチンの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・動物自家ワクチンのヨーロッパ市場分析 - ：動物自家ワクチンのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：動物自家ワクチンのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・動物自家ワクチンのアジア太平洋市場分析 - 動物自家ワクチンのアジア太平洋市場：タイプ別市場規模2017年-2028年 - 動物自家ワクチンのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・動物自家ワクチンの南米市場分析 - 動物自家ワクチンの南米市場：タイプ別市場規模2017年-2028年 - 動物自家ワクチンの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・動物自家ワクチンの中東・アフリカ市場分析 - 動物自家ワクチンの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 動物自家ワクチンの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Animal Autogenous Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Animal Autogenous Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Large Farms accounting for % of the Animal Autogenous Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Poultry segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Animal Autogenous Vaccines include Boehringer Ingelheim International, ZOETIS, Gallant Custom Laboratories, Ceva Biovac, and Dyntec sro, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Animal Autogenous Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Poultry
Pigs
Cattles
Fishes
Other
Market segment by Application can be divided into
Large Farms
Family Farms
The key market players for global Animal Autogenous Vaccines market are listed below:
Boehringer Ingelheim International
ZOETIS
Gallant Custom Laboratories
Ceva Biovac
Dyntec sro
UVAXX Pte Ltd
Deltamune Animal Health
Genova Labs
Hygieia Biological Laboratories
Vaxxinova
Elanco Animal Health
Addison Biological Laboratory
Phibro Animal Health Corporation
Lohmann Tierzucht
RIPAC-LABOR GmbH
Aquatic Biologicals
Merck
BS-IMMUN GmbH
Ridgeway Biologicals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Animal Autogenous Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Animal Autogenous Vaccines, with price, sales, revenue and global market share of Animal Autogenous Vaccines from 2019 to 2022.
Chapter 3, the Animal Autogenous Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Animal Autogenous Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Animal Autogenous Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Animal Autogenous Vaccines.
Chapter 13, 14, and 15, to describe Animal Autogenous Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Animal Autogenous Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Animal Autogenous Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Poultry
1.2.3 Pigs
1.2.4 Cattles
1.2.5 Fishes
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Animal Autogenous Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Large Farms
1.3.3 Family Farms
1.4 Global Animal Autogenous Vaccines Market Size & Forecast
1.4.1 Global Animal Autogenous Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Animal Autogenous Vaccines Sales in Volume (2017-2028)
1.4.3 Global Animal Autogenous Vaccines Price (2017-2028)
1.5 Global Animal Autogenous Vaccines Production Capacity Analysis
1.5.1 Global Animal Autogenous Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Animal Autogenous Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Animal Autogenous Vaccines Market Drivers
1.6.2 Animal Autogenous Vaccines Market Restraints
1.6.3 Animal Autogenous Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Boehringer Ingelheim International
2.1.1 Boehringer Ingelheim International Details
2.1.2 Boehringer Ingelheim International Major Business
2.1.3 Boehringer Ingelheim International Animal Autogenous Vaccines Product and Services
2.1.4 Boehringer Ingelheim International Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 ZOETIS
2.2.1 ZOETIS Details
2.2.2 ZOETIS Major Business
2.2.3 ZOETIS Animal Autogenous Vaccines Product and Services
2.2.4 ZOETIS Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Gallant Custom Laboratories
2.3.1 Gallant Custom Laboratories Details
2.3.2 Gallant Custom Laboratories Major Business
2.3.3 Gallant Custom Laboratories Animal Autogenous Vaccines Product and Services
2.3.4 Gallant Custom Laboratories Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Ceva Biovac
2.4.1 Ceva Biovac Details
2.4.2 Ceva Biovac Major Business
2.4.3 Ceva Biovac Animal Autogenous Vaccines Product and Services
2.4.4 Ceva Biovac Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Dyntec sro
2.5.1 Dyntec sro Details
2.5.2 Dyntec sro Major Business
2.5.3 Dyntec sro Animal Autogenous Vaccines Product and Services
2.5.4 Dyntec sro Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 UVAXX Pte Ltd
2.6.1 UVAXX Pte Ltd Details
2.6.2 UVAXX Pte Ltd Major Business
2.6.3 UVAXX Pte Ltd Animal Autogenous Vaccines Product and Services
2.6.4 UVAXX Pte Ltd Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Deltamune Animal Health
2.7.1 Deltamune Animal Health Details
2.7.2 Deltamune Animal Health Major Business
2.7.3 Deltamune Animal Health Animal Autogenous Vaccines Product and Services
2.7.4 Deltamune Animal Health Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Genova Labs
2.8.1 Genova Labs Details
2.8.2 Genova Labs Major Business
2.8.3 Genova Labs Animal Autogenous Vaccines Product and Services
2.8.4 Genova Labs Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Hygieia Biological Laboratories
2.9.1 Hygieia Biological Laboratories Details
2.9.2 Hygieia Biological Laboratories Major Business
2.9.3 Hygieia Biological Laboratories Animal Autogenous Vaccines Product and Services
2.9.4 Hygieia Biological Laboratories Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Vaxxinova
2.10.1 Vaxxinova Details
2.10.2 Vaxxinova Major Business
2.10.3 Vaxxinova Animal Autogenous Vaccines Product and Services
2.10.4 Vaxxinova Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Elanco Animal Health
2.11.1 Elanco Animal Health Details
2.11.2 Elanco Animal Health Major Business
2.11.3 Elanco Animal Health Animal Autogenous Vaccines Product and Services
2.11.4 Elanco Animal Health Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Addison Biological Laboratory
2.12.1 Addison Biological Laboratory Details
2.12.2 Addison Biological Laboratory Major Business
2.12.3 Addison Biological Laboratory Animal Autogenous Vaccines Product and Services
2.12.4 Addison Biological Laboratory Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Phibro Animal Health Corporation
2.13.1 Phibro Animal Health Corporation Details
2.13.2 Phibro Animal Health Corporation Major Business
2.13.3 Phibro Animal Health Corporation Animal Autogenous Vaccines Product and Services
2.13.4 Phibro Animal Health Corporation Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Lohmann Tierzucht
2.14.1 Lohmann Tierzucht Details
2.14.2 Lohmann Tierzucht Major Business
2.14.3 Lohmann Tierzucht Animal Autogenous Vaccines Product and Services
2.14.4 Lohmann Tierzucht Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 RIPAC-LABOR GmbH
2.15.1 RIPAC-LABOR GmbH Details
2.15.2 RIPAC-LABOR GmbH Major Business
2.15.3 RIPAC-LABOR GmbH Animal Autogenous Vaccines Product and Services
2.15.4 RIPAC-LABOR GmbH Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Aquatic Biologicals
2.16.1 Aquatic Biologicals Details
2.16.2 Aquatic Biologicals Major Business
2.16.3 Aquatic Biologicals Animal Autogenous Vaccines Product and Services
2.16.4 Aquatic Biologicals Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Merck
2.17.1 Merck Details
2.17.2 Merck Major Business
2.17.3 Merck Animal Autogenous Vaccines Product and Services
2.17.4 Merck Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 BS-IMMUN GmbH
2.18.1 BS-IMMUN GmbH Details
2.18.2 BS-IMMUN GmbH Major Business
2.18.3 BS-IMMUN GmbH Animal Autogenous Vaccines Product and Services
2.18.4 BS-IMMUN GmbH Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Ridgeway Biologicals
2.19.1 Ridgeway Biologicals Details
2.19.2 Ridgeway Biologicals Major Business
2.19.3 Ridgeway Biologicals Animal Autogenous Vaccines Product and Services
2.19.4 Ridgeway Biologicals Animal Autogenous Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Animal Autogenous Vaccines Breakdown Data by Manufacturer
3.1 Global Animal Autogenous Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Animal Autogenous Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Animal Autogenous Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Animal Autogenous Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Animal Autogenous Vaccines Manufacturer Market Share in 2021
3.5 Global Animal Autogenous Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Animal Autogenous Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Animal Autogenous Vaccines Market Size by Region
4.1.1 Global Animal Autogenous Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Animal Autogenous Vaccines Revenue by Region (2017-2028)
4.2 North America Animal Autogenous Vaccines Revenue (2017-2028)
4.3 Europe Animal Autogenous Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Animal Autogenous Vaccines Revenue (2017-2028)
4.5 South America Animal Autogenous Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Animal Autogenous Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Animal Autogenous Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Animal Autogenous Vaccines Revenue by Type (2017-2028)
5.3 Global Animal Autogenous Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Animal Autogenous Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Animal Autogenous Vaccines Revenue by Application (2017-2028)
6.3 Global Animal Autogenous Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Animal Autogenous Vaccines Sales by Type (2017-2028)
7.2 North America Animal Autogenous Vaccines Sales by Application (2017-2028)
7.3 North America Animal Autogenous Vaccines Market Size by Country
7.3.1 North America Animal Autogenous Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Animal Autogenous Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Animal Autogenous Vaccines Sales by Type (2017-2028)
8.2 Europe Animal Autogenous Vaccines Sales by Application (2017-2028)
8.3 Europe Animal Autogenous Vaccines Market Size by Country
8.3.1 Europe Animal Autogenous Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Animal Autogenous Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Animal Autogenous Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Animal Autogenous Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Animal Autogenous Vaccines Market Size by Region
9.3.1 Asia-Pacific Animal Autogenous Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Animal Autogenous Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Animal Autogenous Vaccines Sales by Type (2017-2028)
10.2 South America Animal Autogenous Vaccines Sales by Application (2017-2028)
10.3 South America Animal Autogenous Vaccines Market Size by Country
10.3.1 South America Animal Autogenous Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Animal Autogenous Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Animal Autogenous Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Animal Autogenous Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Animal Autogenous Vaccines Market Size by Country
11.3.1 Middle East & Africa Animal Autogenous Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Animal Autogenous Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Animal Autogenous Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Animal Autogenous Vaccines
12.3 Animal Autogenous Vaccines Production Process
12.4 Animal Autogenous Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Animal Autogenous Vaccines Typical Distributors
13.3 Animal Autogenous Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer